The hard work of building businesses is what drives returns for investors, but maximising value also means buying well and selling well. As your advisers, we can make a big difference to the outcome.
Our deep sector knowledge and long-established international network mean we can offer insights on industry trends, strategic positioning and competitive intelligence that give us an edge over generalist advisers. This specialism is allied to buy-side and sell-side M&A expertise across the full range of deal structures – from growth capital to minority stake sales, buy-outs and strategic exits.
Whether you are a venture capital provider, buyout fund, family office or infrastructure investor, we understand your objectives and have the capability to help you achieve them.
Crucially, we work together as one-team. We collaborate and work with partners, and our carefully nurtured internal culture permeates through the whole organisation. As Managing Partner, Julie Langley puts it, “For Results, every deal is important to everybody in our firm.”
Deals are incredibly complex and never straightforward, but we never give up once we are on board. 100 per cent of the deals we’ve closed are referenceable from our past clients.
We’ve been providing independent M&A and corporate finance advice and execution services to entrepreneurs, corporates and investors in the technology and healthcare sectors for over 30 years. Whether your aim is to realise value or to find a partner for future growth, we will be your guide.
When the time comes, we’re by your side every step of the way. We help you evaluate your market, find the right buyer, and deliver the true value of your business.
With a strong track record in company carve-outs, we can help you realign your portfolio and redeploy capital to the growth of your core business.
We support clients with in-licensing, out-licensing, drug licensing, and facility licensing and we understand the complexities that are unique to licensing deals.
We understand that optimising terms is critical, but so is finding the right partner for growth. We help articulate your equity story, target the best investors and negotiate the right deal.
Having completed over 300 transactions, we bring the breadth of perspectives and depth of business experience to provide advice on strategic options for businesses.
Results. Great people creating great outcomes, together.
CDMO Market Update
We are pleased to share with you the CDMO Market Update – November 2021, where we analyse global M&A activity and public market valuations in the CDMO sector. H1 2021 was an exceptional start to the year with 48 deals in total in the CDMO sector, almost reaching the total annual transactions in the previous four […]
Marketing Services: Global M&A and Public Company Performance Q3 2021
We are pleased to share with you the Q3 2021 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. The M&A market for Marketing Services remains buoyant and dynamic with Q1-Q3 2021 deal volume up by 30% on the comparative period at 569 and 441 […]
The Technology Services Perspective – Q3 2021
Deal activity this quarter continues to be driven by strong confidence in acquiring capability in next-gen, modernisation and cloud-first tech stacks, and premium services. Equally, capturing the end-to-end digital transformation value chain continues to be a key M&A theme to become the strategic operator and engineering partner of choice for large-scale budgets. Public tech companies […]